Filing Flows

Filing Flows › Pyxis Oncology (PYXS) › Next earnings date

Pyxis Oncology (PYXS) earnings: beat the estimate

Pyxis Oncology (PYXS) reported on Nov 5, 2026 and beat the EPS estimate: −$0.24 against −$0.28 (+13.6%). It beat the EPS estimate in 40% of the quarters on record.

Last result+13.6% vs estimate
Beat rate40%

The last report

Pyxis Oncology reported revenue of $11.0M for the fourth quarter 2025, net loss $18.1M. How it makes money → · Every quarter →

Pyxis Oncology: EPS against the estimate, last 5 reportsPyxis Oncology: EPS against the estimate, last 5 reportsEstimateReported−$0.34−$0.35Nov 25−$0.34−$0.29Mar 26−$0.35−$0.37May 26−$0.35−$0.40Aug 26−$0.28−$0.24Nov 26
Latest (Nov 26): Estimate −$0.28, Reported −$0.24.

Pyxis Oncology's latest quarter

Pyxis Oncology, Q4 2025: revenue $11.0M, operating margin -165.7%, net loss $18.1M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.

Questions

Did Pyxis Oncology beat earnings?

Pyxis Oncology (PYXS) reported on Nov 5, 2026 and beat the EPS estimate: −$0.24 against −$0.28 (+13.6%).

When does PYXS report earnings?

The next date is not set yet.

Does Pyxis Oncology usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.